山东医药
山東醫藥
산동의약
SHANDONG MEDICAL JOURNAL
2014年
25期
21-23
,共3页
袁利梅%赵德英%邱惠%谢丛华%张弓%周福祥
袁利梅%趙德英%邱惠%謝叢華%張弓%週福祥
원리매%조덕영%구혜%사총화%장궁%주복상
宫颈肿瘤%生存率%预后%单因素分析%多因素分析
宮頸腫瘤%生存率%預後%單因素分析%多因素分析
궁경종류%생존솔%예후%단인소분석%다인소분석
cervical neoplasms%survival rate%prognosis%univariate analysis%multivariate analysis
目的:通过分析宫颈癌患者的临床资料,探讨影响其预后的临床病理因素。方法回顾性分析195例宫颈癌患者的临床资料。结果单因素分析显示,宫颈癌临床Ⅰ期、Ⅱ期、Ⅲ期+Ⅳ期患者的5年生存率分别为88.2%、70.4%、39.3%,,不同分期间比较,P均<0.01;接受手术与未接受手术者的5年生存率分别为70.1%、40.5%,两者比较,P<0.01;腹膜后淋巴结转移与无腹膜后淋巴结转移者的2年生存率分别为20.4%、84.1%,两者比较,P<0.01。多因素分析显示,临床分期、手术、腹膜后淋巴结转移是影响宫颈癌患者总生存率的独立因素( P<0.05或<0.01)。结论临床分期、手术、腹膜后淋巴结转移与宫颈癌的预后显著相关。
目的:通過分析宮頸癌患者的臨床資料,探討影響其預後的臨床病理因素。方法迴顧性分析195例宮頸癌患者的臨床資料。結果單因素分析顯示,宮頸癌臨床Ⅰ期、Ⅱ期、Ⅲ期+Ⅳ期患者的5年生存率分彆為88.2%、70.4%、39.3%,,不同分期間比較,P均<0.01;接受手術與未接受手術者的5年生存率分彆為70.1%、40.5%,兩者比較,P<0.01;腹膜後淋巴結轉移與無腹膜後淋巴結轉移者的2年生存率分彆為20.4%、84.1%,兩者比較,P<0.01。多因素分析顯示,臨床分期、手術、腹膜後淋巴結轉移是影響宮頸癌患者總生存率的獨立因素( P<0.05或<0.01)。結論臨床分期、手術、腹膜後淋巴結轉移與宮頸癌的預後顯著相關。
목적:통과분석궁경암환자적림상자료,탐토영향기예후적림상병리인소。방법회고성분석195례궁경암환자적림상자료。결과단인소분석현시,궁경암림상Ⅰ기、Ⅱ기、Ⅲ기+Ⅳ기환자적5년생존솔분별위88.2%、70.4%、39.3%,,불동분기간비교,P균<0.01;접수수술여미접수수술자적5년생존솔분별위70.1%、40.5%,량자비교,P<0.01;복막후림파결전이여무복막후림파결전이자적2년생존솔분별위20.4%、84.1%,량자비교,P<0.01。다인소분석현시,림상분기、수술、복막후림파결전이시영향궁경암환자총생존솔적독립인소( P<0.05혹<0.01)。결론림상분기、수술、복막후림파결전이여궁경암적예후현저상관。
Objective To explore the key prognostic factors in patients with cervical cancer by analyzing the clinical data.Methods The clinical data of 195 patients with cervical cancer were retrospectively analyzed .Results According to the univariate analysis, the 5-year survival rates for stage Ⅰ,Ⅱ,Ⅲ+Ⅳwere 88.2%, 70.4%and 39.3%, respec-tively (all P<0.01).The 5-year survival rate of patients undergoing surgery was higher than that of patients who did not undergo surgery (70.1%vs 40.5%, P<0.01).The 2-year survival rates of patients with and without retroperitoneal lymph node metastasis were 20.4%and 84.1%(P<0.01).Multivariate analysis demonstrated that stage , surgical treat-ment and retroperitoneal lymph node metastasis were independent prognostic factors for patients with cervical cancer .Con-clusion The clinical stages , surgical treatment and retroperitoneal lymph node metastasis are significantly associated with the prognosis of patients with cervical cancer .